A 68-year-old diabetic woman presented to the Cen ter for Voice and Swallowing with progressive dyspn ea and dysp honia of 5 years' duration. She was a lifelong nonsmoker. Her med ical history was notable for a right subtotal thyroidectomy for benign disease 50 yea rs earlie r. That surge ry had been complicated by right voca l fold paralysis, and 3 1 years later, she underwen t an injec tion medialization with Teflon at another institution.
At our ce nter, fiberoptic nasopharyngeal laryngoscopy revea led the presence of a right subm uco sa l mass that extended fro m the right true vocal fold to the subglottic regio n. The diame ter of the airway was 3 to 4 mm . No granulatio n tissue was apprec iated . Findings on the rema inder of the head and nec k examination were normal.
Contrast-enhance d computed tom ography (CT) of the neck demonstrated a large heterogeneou s mass at the level of the rig ht true voca l fold (figure I). No cervical lymph adenopath y was ide ntified.
The patient und erwent excis ion of the well-circ umscribed mass via a right laryngotomy approach (figure 2) . Th e voca l fold was medialized with an inferiorly based thyrohyoid muscle flap, and an arytenoid adduction was performed through the laryngotomy windo w. The patient underwe nt a tracheotomy durin g the procedure to sec ure a severely co mpro mise d airway. Pathology revealed a Teflon granuloma (figure 3).
The patient did well postoperatively, and she was decannulated on postoperative day 9 without com plication. Transnasal fiberoptic laryngoscopy and trache obron choscopy revealed a well-media lized right voca l fol d with co mplete glotta l closure. Th e airway was wide ly patent.
Teflon (polyte trafluoroethy lene) has been supplanted by other mate rials because it is associated with a risk of gra nuloma formation after superfic ial injection, as well as a risk of migration . Also, Teflon has been kn own to stiffen the mucosa l wave, and it ca n be difficult to remove. The reported incidence of Teflon gran uloma is 2 to 3%,I but its true incidence may be higher.
Patients with Teflon gra nuloma likely fall into one of two groups : ( I) tho se with an imm edi ate reaction to ove rinject ion or imp roper inj ection and (2) matous response.' The dur ation between Teflon injection and granuloma removal has been reported to range from 4 months to 18 years (mea n: 55 mo), which sugges ts that the inflammatory reaction to Teflon is highly variable.' Teflon granulomas can be surgically managed via an endoscop ic, open, or comb ined approach.' Many consider gra nuloma removal throu gh a large laryngotomy window with strap muscle reconstruction and arytenoid adducti on to be the surgical treatment of choice.'
